強度変調放射線治療（IMRT）市場の2030年までの予測：放射線タイプ、用途、エンドユーザー、地域別の世界分析

Stratistics MRCによると、強度変調放射線治療（IMRT）の世界市場は2023年に22億米ドルを占め、予測期間中にCAGR 6.8％で成長し、2030年には35億米ドルに達すると予測されています。

強度変調放射線治療（IMRT）（IMRT）は、複数の角度にわたって放射線ビーム強度を調整する精密な放射線治療技術です。これにより、周囲の健康な構造物への被曝を最小限に抑えながら、がん組織への高線量照射が可能になります。IMRTの精度は、従来の放射線療法に比べて治療効果を高め、副作用を軽減します。

米国がん協会によると、2022年には米国で新たに190万人のがん患者が発生すると推定されています。

世界中で増加するがんの有病率

がんの罹患率は世界中で急上昇を続けており、高度で精密な治療法に対する需要が高まっています。IMRTは、周囲の健康な組織へのダメージを最小限に抑えながら、狙いを定めた線量を照射する能力を備えており、腫瘍学の状況において極めて重要な技術として浮上しています。多様な種類のがんの有病率の上昇と高齢化により、効果的でオーダーメイドの治療法の必要性が高まっています。この動向は、IMRTを包括的ながん治療の主要な担い手として採用することを後押しし、IMRTを進化するがん治療の展望における重要なソリューションとして位置づけています。

高い治療費

IMRTの高度な技術は、正確な放射線照射、特殊な機器、熟練した人材を伴うため、治療費が高くつく。この経済的負担は、特に医療予算が限られている地域や償還政策が不十分な地域では、ヘルスケア機関や患者の足かせとなる可能性があります。費用面を考慮すると、より費用対効果の高い代替治療法への関心がそがれ、IMRTの市場シェアに影響を与える可能性があるため、この脅威はますます強まっています。

個別化医療の統合

遺伝子構成や腫瘍プロファイルなど、個々の患者の特徴に合わせて治療を調整することは、IMRTの精度と有効性を高める。パーソナライズド・アプローチにより治療計画が最適化され、副作用が最小限に抑えられ、治療成績が向上します。この相乗効果は、ヘルスケアの精密医療に向けた広範な動向と一致し、より患者中心で的を絞った治療アプローチを促進します。IMRTが個別化医療とシームレスに統合できることは、IMRTの適用範囲を拡大するだけでなく、IMRTを最先端の腫瘍治療の最前線に位置づけ、需要と市場成長を促進します。

導入の複雑さ

IMRTの複雑な技術は、放射線腫瘍医や医学物理士を含むヘルスケア専門家に専門的なトレーニングを要求するため、十分なスキルを持つ人材が不足する可能性があります。IMRTに関わる高度な計画および提供プロセスには、高度な機器だけでなく、治療計画ソフトウェアの微妙な理解も必要です。IMRTを既存のヘルスケアシステムに統合するには、インフラへの多額の投資と継続的な教育イニシアチブが必要です。さらに、IMRT技術を習得するための学習曲線は、特に資源が限られている地域やヘルスケア格差のある地域において、迅速かつ広範な普及の妨げとなる可能性があります。

COVID-19の影響：

COVID-19の大流行は市場に大きな影響を与えました。この危機はヘルスケアサービスの混乱につながり、緊急性のないがん治療を含む選択的処置を遅らせた。COVID-19関連の医療への資源の再配分と優先順位付けは、日常的ながん治療のための医療施設の利用可能性を圧迫し、IMRTの採用に影響を与えました。さらに、パンデミック後の経済課題や医療予算の制約が投資決定に影響を及ぼし、市場の成長を鈍化させた可能性もあります。このような挫折にもかかわらず、先進がん治療におけるIMRTの重要性は、医療制度がパンデミック後の進化する状況に適応するにつれて、引き続き回復の原動力となっています。

予測期間中は乳がん分野が最大になる見込み

乳がん分野は有利な成長が見込まれます。IMRTの放射線ビームの調整精度は、周囲の健康な組織への被曝を最小限に抑えながら、乳房腫瘍への標的照射を可能にします。その結果、従来の放射線療法に比べて治療効果が向上し、副作用も軽減されます。乳がん症例におけるIMRTの需要は、世界の乳がん罹患率の上昇に加え、乳がんの放射線療法を受ける患者の治療成績の改善と生活の質の向上に寄与する高度で精密な治療法に対する嗜好の高まりが背景にあります。

予測期間中にCAGRが最も高くなると予想されるのは病院分野です。

予測期間中、CAGRが最も高くなると予測されるのは病院分野です。これらのヘルスケア機関は、最先端のIMRT技術とインフラに投資し、患者が高度な放射線療法を受けられるようにしています。病院は放射線腫瘍医や技師と連携して、正確で個別化されたIMRT治療を提供します。病院内でのIMRTの統合により、がん治療能力が強化され、標的を絞った治療が可能になり、副作用が最小限に抑えられます。主要な利害関係者である病院は、より広範な医療現場におけるIMRTの成長とアクセシビリティに大きく貢献しています。

最もシェアが高い地域：

予測期間中、北米市場が引き続き市場シェアの大半を占めると予想されるが、これは高度なヘルスケアインフラ、高いがん罹患率、活発な研究開発活動が背景にあります。同地域では、保険償還政策が確立されており、技術革新に重点を置いていることが普及に寄与しています。さらに、医療従事者や患者の間でIMRTの利点に対する認識が高まっていることも、市場の存在感を高めています。主要な市場参入企業と研究機関の連携が北米の地位をさらに強固なものにしており、同地域のがん治療の進化するニーズに対応するIMRTソリューションに対する需要の継続的な急増を確実なものにしています。

CAGRが最も高い地域：

アジア太平洋地域は、スパイスラム市場において重要な役割を担っており、がん罹患率の増加、ヘルスケアインフラの進歩、高度な治療オプションに対する意識の高まりを背景に、予測期間中のCAGRが最も高くなると予測されています。中国、インド、日本のような国々は、がん医療への投資の増加により、この拡大の最前線にいます。この地域の大規模な患者プールは、がん治療を改善するための政府の取り組みと相まって、IMRT採用のための肥沃な土壌を作り出しています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• アプリケーション分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の強度変調放射線治療（IMRT）市場：放射線タイプ別

• 陽子線
• 電子放射線
• 光子放射線
• 炭素イオン放射線
• 他の種類の放射線

第6章 世界の強度変調放射線治療（IMRT）市場：用途別

• 前立腺がん
• 肺がん
• 乳がん
• 脳腫瘍
• 婦人科がん
• その他の用途

第7章 世界の強度変調放射線治療（IMRT）市場：エンドユーザー別

• 病院
• 独立型放射線治療センター
• その他のエンドユーザー

第8章 世界の強度変調放射線治療（IMRT）市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第9章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイル

• Accuray Incorporated
• Brainlab AG
• Varian Medical Systems, Inc
• Elekta AB
• Hitachi, Ltd.
• IBA Worldwide
• Koninklijke Philips N.V.
• Mevion Medical Systems
• Mitsubishi Electric Corporation
• Raysearch Laboratories
• Siemens Healthineers AG

List of Tables

• Table 1 Global Intensity Modulated Radiation Therapy Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2021-2030) ($MN)
• Table 3 Global Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2021-2030) ($MN)
• Table 4 Global Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2021-2030) ($MN)
• Table 5 Global Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2021-2030) ($MN)
• Table 6 Global Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2021-2030) ($MN)
• Table 7 Global Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2021-2030) ($MN)
• Table 8 Global Intensity Modulated Radiation Therapy Market Outlook, By Application (2021-2030) ($MN)
• Table 9 Global Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
• Table 10 Global Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
• Table 11 Global Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
• Table 12 Global Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2021-2030) ($MN)
• Table 13 Global Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2021-2030) ($MN)
• Table 14 Global Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 15 Global Intensity Modulated Radiation Therapy Market Outlook, By End User (2021-2030) ($MN)
• Table 16 Global Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 17 Global Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2021-2030) ($MN)
• Table 18 Global Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 19 North America Intensity Modulated Radiation Therapy Market Outlook, By Country (2021-2030) ($MN)
• Table 20 North America Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2021-2030) ($MN)
• Table 21 North America Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2021-2030) ($MN)
• Table 22 North America Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2021-2030) ($MN)
• Table 23 North America Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2021-2030) ($MN)
• Table 24 North America Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2021-2030) ($MN)
• Table 25 North America Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2021-2030) ($MN)
• Table 26 North America Intensity Modulated Radiation Therapy Market Outlook, By Application (2021-2030) ($MN)
• Table 27 North America Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
• Table 28 North America Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
• Table 29 North America Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
• Table 30 North America Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2021-2030) ($MN)
• Table 31 North America Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2021-2030) ($MN)
• Table 32 North America Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 33 North America Intensity Modulated Radiation Therapy Market Outlook, By End User (2021-2030) ($MN)
• Table 34 North America Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 35 North America Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2021-2030) ($MN)
• Table 36 North America Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 37 Europe Intensity Modulated Radiation Therapy Market Outlook, By Country (2021-2030) ($MN)
• Table 38 Europe Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2021-2030) ($MN)
• Table 39 Europe Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2021-2030) ($MN)
• Table 40 Europe Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2021-2030) ($MN)
• Table 41 Europe Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2021-2030) ($MN)
• Table 42 Europe Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2021-2030) ($MN)
• Table 43 Europe Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2021-2030) ($MN)
• Table 44 Europe Intensity Modulated Radiation Therapy Market Outlook, By Application (2021-2030) ($MN)
• Table 45 Europe Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
• Table 46 Europe Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
• Table 47 Europe Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
• Table 48 Europe Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2021-2030) ($MN)
• Table 49 Europe Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2021-2030) ($MN)
• Table 50 Europe Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 51 Europe Intensity Modulated Radiation Therapy Market Outlook, By End User (2021-2030) ($MN)
• Table 52 Europe Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 53 Europe Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2021-2030) ($MN)
• Table 54 Europe Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 55 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Country (2021-2030) ($MN)
• Table 56 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2021-2030) ($MN)
• Table 57 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2021-2030) ($MN)
• Table 58 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2021-2030) ($MN)
• Table 59 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2021-2030) ($MN)
• Table 60 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2021-2030) ($MN)
• Table 61 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2021-2030) ($MN)
• Table 62 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Application (2021-2030) ($MN)
• Table 63 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
• Table 64 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
• Table 65 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
• Table 66 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2021-2030) ($MN)
• Table 67 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2021-2030) ($MN)
• Table 68 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 69 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By End User (2021-2030) ($MN)
• Table 70 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 71 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2021-2030) ($MN)
• Table 72 Asia Pacific Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 73 South America Intensity Modulated Radiation Therapy Market Outlook, By Country (2021-2030) ($MN)
• Table 74 South America Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2021-2030) ($MN)
• Table 75 South America Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2021-2030) ($MN)
• Table 76 South America Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2021-2030) ($MN)
• Table 77 South America Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2021-2030) ($MN)
• Table 78 South America Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2021-2030) ($MN)
• Table 79 South America Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2021-2030) ($MN)
• Table 80 South America Intensity Modulated Radiation Therapy Market Outlook, By Application (2021-2030) ($MN)
• Table 81 South America Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
• Table 82 South America Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
• Table 83 South America Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
• Table 84 South America Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2021-2030) ($MN)
• Table 85 South America Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2021-2030) ($MN)
• Table 86 South America Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 87 South America Intensity Modulated Radiation Therapy Market Outlook, By End User (2021-2030) ($MN)
• Table 88 South America Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 89 South America Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2021-2030) ($MN)
• Table 90 South America Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 91 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Country (2021-2030) ($MN)
• Table 92 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Radiation Type (2021-2030) ($MN)
• Table 93 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Proton Radiation (2021-2030) ($MN)
• Table 94 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Electron Radiation (2021-2030) ($MN)
• Table 95 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Photon Radiation (2021-2030) ($MN)
• Table 96 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Carbon Ion Radiation (2021-2030) ($MN)
• Table 97 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Other Radiation Types (2021-2030) ($MN)
• Table 98 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Application (2021-2030) ($MN)
• Table 99 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
• Table 100 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
• Table 101 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
• Table 102 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Brain Cancer (2021-2030) ($MN)
• Table 103 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Gynecological Cancer (2021-2030) ($MN)
• Table 104 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 105 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By End User (2021-2030) ($MN)
• Table 106 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 107 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Standalone Radiation Therapy Centers (2021-2030) ($MN)
• Table 108 Middle East & Africa Intensity Modulated Radiation Therapy Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Intensity Modulated Radiation Therapy Market is accounted for $2.2 billion in 2023 and is expected to reach $3.5 billion by 2030 growing at a CAGR of 6.8% during the forecast period. Intensity Modulated Radiation Therapy (IMRT) is a precise radiotherapy technique that adjusts radiation beam intensity across multiple angles. This allows targeted delivery of higher doses to cancerous tissue while minimizing exposure to surrounding healthy structures. IMRT's precision enhances treatment effectiveness and reduces side effects compared to conventional radiation therapy.

According to the American Cancer Society, in 2022, an estimated 1.9 million new cases of cancer were diagnosed in the U.S.

Market Dynamics:

Driver:

The rising prevalence of cancer worldwide

Cancer rates continue to surge worldwide, there is a heightened demand for advanced and precise treatment modalities. IMRT, with its ability to deliver targeted radiation doses while minimizing damage to surrounding healthy tissues, have emerged as a crucial technology in the oncology landscape. The rising prevalence of diverse cancer types, coupled with an aging population, underscores the need for effective and tailored therapies. This trend propels the adoption of IMRT as a key player in the comprehensive oncological care, positioning it as a vital solution in the evolving landscape of cancer treatment.

Restraint:

High treatment costs

IMRT's sophisticated technology, involving precise radiation delivery, specialized equipment, and skilled personnel, contributes to elevated treatment expenses. This financial burden may deter healthcare institutions and patients, particularly in regions with limited healthcare budgets or where reimbursement policies are insufficient. The threat intensifies as cost considerations may divert attention toward alternative, more cost-effective treatment options, impacting IMRT's market share.

Opportunity:

Personalized medicine integration

Tailoring treatments to individual patient characteristics, such as genetic makeup and tumor profiles, enhances the precision and effectiveness of IMRT. Personalized approaches allow for optimized treatment plans, minimizing side effects and improving outcomes. This synergy aligns with the broader trend in healthcare towards precision medicine, fostering a more patient-centric and targeted therapeutic approach. The ability of IMRT to seamlessly integrate with personalized medicine not only expands its applicability but also positions it at the forefront of cutting-edge oncological care, driving demand and market growth.

Threat:

Complexity of implementation

IMRT's intricate technology demands specialized training for healthcare professionals, including radiation oncologists and medical physicists, leading to a potential shortage of adequately skilled personnel. The sophisticated planning and delivery processes involved in IMRT require not only advanced equipment but also a nuanced understanding of treatment planning software. Integration of IMRT into existing healthcare systems necessitates substantial investments in infrastructure and continuous educational initiatives. Moreover, the learning curve for mastering IMRT techniques may hinder its swift and widespread adoption, particularly in regions with limited resources or healthcare disparities.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the market. The crisis led to disruptions in healthcare services, delaying elective procedures, including non-urgent cancer treatments. Resource reallocation and prioritization of COVID-19-related care strained the availability of medical facilities for routine cancer therapies, affecting the adoption of IMRT. Moreover, economic challenges and healthcare budget constraints in the wake of the pandemic may have influenced investment decisions, potentially slowing down the market's growth. Despite these setbacks, the importance of IMRT in advanced cancer care continues to drive its recovery as healthcare systems adapt to the evolving post-pandemic landscape.

The breast cancer segment is expected to be the largest during the forecast period

The breast cancer segment is expected to have a lucrative growth. IMRT's precision in adjusting radiation beams allows for targeted delivery to breast tumors while minimizing exposure to surrounding healthy tissue. This results in enhanced treatment efficacy and reduced side effects compared to conventional radiation therapy. The demand for IMRT in breast cancer cases is driven by the rising incidence of breast cancer globally, coupled with the increasing preference for advanced and precise treatment modalities that contribute to improved outcomes and better quality of life for patients undergoing radiation therapy for breast cancer.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to witness the highest CAGR growth during the forecast period. These healthcare institutions invest in state-of-the-art IMRT technology and infrastructure, ensuring access to advanced radiation therapies for patients. Hospitals collaborate with radiation oncologists and technologists to deliver precise and personalized IMRT treatments. The integration of IMRT within hospital settings enhances cancer care capabilities, allowing for targeted therapy delivery and minimizing side effects. As key stakeholders, hospitals contribute significantly to the growth and accessibility of IMRT in the broader healthcare landscape.

Region with largest share:

During the forecast period, it is expected that the North American market will continue to hold a majority of the market share, driven by advanced healthcare infrastructure, a high prevalence of cancer, and robust R&D activities. The region's well-established reimbursement policies and a strong focus on technological innovation contribute to widespread adoption. Moreover, increasing awareness about the benefits of IMRT among healthcare professionals and patients enhances its market presence. Collaboration between key market players and research institutions further solidifies North America's position, ensuring a continuous surge in demand for IMRT solutions to address the evolving needs of cancer treatment in the region.

Region with highest CAGR:

The Asia Pacific region plays a significant role in the spice rum market and is projected to have the highest CAGR over the forecast period driven by increasing cancer prevalence, advancing healthcare infrastructure, and rising awareness of advanced treatment options. Countries like China, India, and Japan are at the forefront of this expansion, with growing investments in oncology care. The region's large patient pool, coupled with government initiatives to improve cancer treatment, creates a fertile ground for IMRT adoption.

Key players in the market

Some of the key players in Intensity Modulated Radiation Therapy market include Accuray Incorporated, Brainlab AG, Varian Medical Systems, Inc, Elekta AB, Hitachi, Ltd., IBA Worldwide, Koninklijke Philips N.V., Mevion Medical Systems, Mitsubishi Electric Corporation, Raysearch Laboratories and Siemens Healthineers AG.

Key Developments:

In October 2023, Siemens Healthineers AG Partnered with RefleXion X to develop AI-powered solutions for optimizing IMRT treatment plans.

In June 2023, Elekta AB. acquired Monaco, a leading treatment planning software for IMRT and other modalities.

In November 2022, Accuray unveiled a strategic collaboration with Limbus AI to bolster adaptive radiotherapy solutions. This partnership marked a significant milestone in expanding Accuray's product portfolio, showcasing the company's commitment to advancing cutting-edge technologies in the field of radiotherapy.

Radiation Types Covered:

• Proton Radiation
• Electron Radiation
• Photon Radiation
• Carbon Ion Radiation
• Other Radiation Types

Applications Covered:

• Prostate Cancer
• Lung Cancer
• Breast Cancer
• Brain Cancer
• Gynecological Cancer
• Other Applications

End Users Covered:

• Hospitals
• Standalone Radiation Therapy Centers
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Intensity Modulated Radiation Therapy Market, By Radiation Type

• 5.1 Introduction
• 5.2 Proton Radiation
• 5.3 Electron Radiation
• 5.4 Photon Radiation
• 5.5 Carbon Ion Radiation
• 5.6 Other Radiation Types

6 Global Intensity Modulated Radiation Therapy Market, By Application

• 6.1 Introduction
• 6.2 Prostate Cancer
• 6.3 Lung Cancer
• 6.4 Breast Cancer
• 6.5 Brain Cancer
• 6.6 Gynecological Cancer
• 6.7 Other Applications

7 Global Intensity Modulated Radiation Therapy Market, By End User

• 7.1 Introduction
• 7.2 Hospitals
• 7.3 Standalone Radiation Therapy Centers
• 7.4 Other End Users

8 Global Intensity Modulated Radiation Therapy Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Accuray Incorporated
• 10.2 Brainlab AG
• 10.3 Varian Medical Systems, Inc
• 10.4 Elekta AB
• 10.5 Hitachi, Ltd.
• 10.6 IBA Worldwide
• 10.7 Koninklijke Philips N.V.
• 10.8 Mevion Medical Systems
• 10.9 Mitsubishi Electric Corporation
• 10.10 Raysearch Laboratories
• 10.11 Siemens Healthineers AG